Patent Foramen Ovale Closure Indications: A Clinical Update

S D Med. 2021 Dec;74(12):559-560.

Abstract

Patent foramen ovale (PFO) is a commonly identified congenital cardiac defect, present in 25-30 percent of adults. Though usually clinically silent, PFOs can result in paradoxical embolization, resulting in platypnea-orthodeoxia syndrome (POS), migraines, myocardial infarctions, or cerebrovascular accidents. Patients with incidentally noted PFOs should be managed conservatively, but in patients with cryptogenic stroke and amenable anatomy, closure with a percutaneous closure device is recommended.

MeSH terms

  • Adult
  • Cardiac Catheterization
  • Dyspnea
  • Foramen Ovale, Patent* / complications
  • Foramen Ovale, Patent* / surgery
  • Humans
  • Septal Occluder Device*
  • Stroke* / etiology
  • Stroke* / prevention & control
  • Treatment Outcome